LHA510 ophthalmic suspension

DRUG2 trials

Sponsors

Alcon Research, Alcon, a Novartis Company

Conditions

Age-Related Macular DegenerationExudative Age-Related Macular Degeneration

Phase 1

First-in-Human Study of LHA510 in Elderly Subjects and Patients With Age-Related Macular Degeneration

CompletedNCT02076919

Alcon ResearchAge-Related Macular Degeneration

Start: 2014-02-28End: 2014-06-30Updated: 2016-04-01

Phase 2

LHA510 Proof-of-Concept Study as a Maintenance Therapy for Patients With Wet Age-Related Macular Degeneration

CompletedNCT02355028

Alcon, a Novartis CompanyExudative Age-Related Macular Degeneration

Start: 2015-03-03End: 2016-10-18Updated: 2018-07-02